Effect of Disease-related Changes in Plasma Albumin on the Pharmacokinetics of Naproxen in Male and Female Arthritic Rats Publication Effect of Disease-related Changes in Plasma Albumin on the Pharmacokinetics of Naproxen in Male and Female Arthritic Rats webdev2017 年 5 月 1 日
CYP2C9 Genotype-dependent Warfarin Pharmacokinetics: Impact of CYP2C9 Genotype on R- and S-Warfarin and Their Oxidative Metabolites Publication CYP2C9 Genotype-dependent Warfarin Pharmacokinetics: Impact of CYP2C9 Genotype on R- and S-Warfarin and Their Oxidative Metabolites webdev2017 年 3 月 1 日
Clarification of Contraceptive Drug Pharmacokinetics in Obesity Publication Clarification of Contraceptive Drug Pharmacokinetics in Obesity webdev2017 年 1 月 1 日
Population Pharmacokinetics and Exposure-response of Osimertinib in Patients with Non-small Cell Lung Cancer Publication Population Pharmacokinetics and Exposure-response of Osimertinib in Patients with Non-small Cell Lung Cancer webdev2016 年 12 月 18 日
Intravenous Topiramate: Pharmacokinetics in Dogs with Naturally Occurring Epilepsy Publication Intravenous Topiramate: Pharmacokinetics in Dogs with Naturally Occurring Epilepsy webdev2016 年 12 月 5 日
The Pharmacokinetics of Transdermal Flunixin Meglumine in Holstein Calves Publication The Pharmacokinetics of Transdermal Flunixin Meglumine in Holstein Calves This study describes the pharmacokinetics of topical and intravenous (IV) flunixin meglumine in Holstein calves.…webdev2016 年 12 月 1 日
Modeling and Experimental Studies of Obeticholic Acid Exposure and the Impact of Cirrhosis Stage Publication Modeling and Experimental Studies of Obeticholic Acid Exposure and the Impact of Cirrhosis Stage webdev2016 年 12 月 1 日
A Randomized Dose Escalation Study of Intravenous Baclofen in Healthy Volunteers: Clinical Tolerance and Pharmacokinetics Publication A Randomized Dose Escalation Study of Intravenous Baclofen in Healthy Volunteers: Clinical Tolerance and Pharmacokinetics webdev2016 年 11 月 17 日
Impact of Target-mediated Elimination on the Dose and Regimen of Evolocumab, a Human Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Publication Impact of Target-mediated Elimination on the Dose and Regimen of Evolocumab, a Human Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) webdev2016 年 11 月 15 日
Modeling and Simulation Guides Dosing for a New Anti-psychotic Drug Blog Modeling and Simulation Guides Dosing for a New Anti-psychotic Drug Drug development is becoming more complex than ever. Regulatory agencies expect sponsors to consider a…Karen Rowland Yeo2016 年 10 月 21 日